List All Chronic Myeloid Leukemia (CML) Trials

Chronic Myeloid Leukemia (CML)

 

Bosutinib for Philadelphia Chromosome Positive CML Previously Treated with One or More Tyrosine Kinase Inhibitors (9238)
A Phase 4 Safety and Efficacy Study of Bosutinib (Bosulif®) in Patients with Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated with One or More Tyrosine Kinase Inhibitors

Investigator: Vivian Oehler, MD;   Conditions: Chronic Myeloid Leukemia (CML);    Status: Recruiting;   Study ID: NCT02228382